Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening

被引:43
|
作者
Lu, Tianyuan [1 ,2 ]
Zhou, Sirui [1 ]
Wu, Haoyu [1 ,3 ]
Forgetta, Vincenzo [1 ]
Greenwood, Celia M. T. [1 ,3 ,4 ,5 ]
Richards, J. Brent [1 ,3 ,4 ,6 ]
机构
[1] Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst Med Res, Montreal, PQ, Canada
[2] McGill Univ, Quantitat Life Sci Program, Montreal, PQ, Canada
[3] McGffl Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[4] McGffl Univ, Dept Human Genet, Montreal, PQ, Canada
[5] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada
[6] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England
基金
加拿大健康研究院;
关键词
rare variants; polygenic risk scores; exome sequencing; patient prioritization; risk stratification; BREAST-CANCER; BIOBANK; PREDICTION; MUTATIONS; DISCOVERY; DIAGNOSIS; GENOME;
D O I
10.1038/s41436-020-01007-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose Identifying rare genetic causes of common diseases can improve diagnostic and treatment strategies, but incurs high costs. We tested whether individuals with common disease and low polygenic risk score (PRS) for that disease generated from less expensive genome-wide genotyping data are more likely to carry rare pathogenic variants. Methods We identified patients with one of five common complex diseases among 44,550 individuals who underwent exome sequencing in the UK Biobank. We derived PRS for these five diseases, and identified pathogenic rare variant heterozygotes. We tested whether individuals with disease and low PRS were more likely to carry rare pathogenic variants. Results While rare pathogenic variants conferred, at most, 5.18-fold (95% confidence interval [CI]: 2.32-10.13) increased odds of disease, a standard deviation increase in PRS, at most, increased the odds of disease by 5.25-fold (95% CI: 5.06-5.45). Among diseased patients, a standard deviation decrease in the PRS was associated with, at most, 2.82-fold (95% CI: 1.14-7.46) increased odds of identifying rare variant heterozygotes. Conclusion Rare pathogenic variants were more prevalent among affected patients with a low PRS. Therefore, prioritizing individuals for sequencing who have disease but low PRS may increase the yield of sequencing studies to identify rare variant heterozygotes.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
  • [1] Common Variant Polygenic Risk Score Influences Penetrance of Rare Variants in Monogenic Diabetes Genes
    Huerta, Alicia
    Mandla, Ravi
    Nagy, Dorka
    Szczerbinski, Lukasz
    Madsen, Jesper G. S.
    Cole, Joanne B.
    Porneala, Bianca
    Westerman, Kenneth E.
    Li, Josephine H.
    Pollin, Toni I.
    Florez, Jose C.
    Gloyn, Anna L.
    Cebola, Ines
    Manning, Alisa
    Leong, Aaron
    Udler, Miriam
    Mercader, Josep M.
    DIABETES, 2024, 73
  • [2] Patients with a low PRS should be prioritized to rare variant screening
    Lu, Tianyuan
    Zhou, Sirui
    Wu, Haoyu
    Forgetta, Vincenzo
    Greenwood, Celia M. T.
    Richards, J. Brent
    GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 504 - 504
  • [3] Polygenic risk score portability for common diseases across genetically diverse populations
    Moreno-Grau, Sonia
    Vernekar, Manvi
    Lopez-Pineda, Arturo
    Mas-Montserrat, Daniel
    Barrabes, Miriam
    Quinto-Cortes, Consuelo D.
    Moatamed, Babak
    Lee, Ming Ta Michael
    Yu, Zhenning
    Numakura, Kensuke
    Matsuda, Yuta
    Wall, Jeffrey D.
    Ioannidis, Alexander G.
    Katsanis, Nicholas
    Takano, Tomohiro
    Bustamante, Carlos D.
    HUMAN GENOMICS, 2024, 18 (01)
  • [4] Assessment of polygenic risk score performance in East Asian populations for ten common diseases
    Jung, Hae-Un
    Jung, Hyein
    Baek, Eun Ju
    Kang, Ji-One
    Kwon, Shin Young
    You, Jaeyoon
    Lim, Ji Eun
    Oh, Bermseok
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
  • [5] Contextualizing genetic risk score for disease screening and rare variant discovery
    Zhou, Dan
    Yu, Dongmei
    Scharf, Jeremiah M.
    Mathews, Carol A.
    McGrath, Lauren
    Cook, Edwin
    Lee, S. Hong
    Davis, Lea K.
    Gamazon, Eric R.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [6] Contextualizing genetic risk score for disease screening and rare variant discovery
    Dan Zhou
    Dongmei Yu
    Jeremiah M. Scharf
    Carol A. Mathews
    Lauren McGrath
    Edwin Cook
    S. Hong Lee
    Lea K. Davis
    Eric R. Gamazon
    Nature Communications, 12
  • [7] Distribution of 54 polygenic risk scores for common diseases in long lived individuals and their offspring
    Sophia Gunn
    Michael Wainberg
    Zeyuan Song
    Stacy Andersen
    Robert Boudreau
    Mary F. Feitosa
    Qihua Tan
    May E. Montasser
    Jeffrey R. O’Connell
    Nathan Stitziel
    Nathan Price
    Thomas Perls
    Nicholas J. Schork
    Paola Sebastiani
    GeroScience, 2022, 44 : 719 - 729
  • [8] Distribution of 54 polygenic risk scores for common diseases in long lived individuals and their offspring
    Gunn, Sophia
    Wainberg, Michael
    Song, Zeyuan
    Andersen, Stacy
    Boudreau, Robert
    Feitosa, Mary F.
    Tan, Qihua
    Montasser, May E.
    O'Connell, Jeffrey R.
    Stitziel, Nathan
    Price, Nathan
    Perls, Thomas
    Schork, Nicholas J.
    Sebastiani, Paola
    GEROSCIENCE, 2022, 44 (02) : 719 - 729
  • [9] Polygenic risk scores and the prediction of common diseases
    Ala-Korpela, Mika
    Holmes, Michael V.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2020, 49 (01) : 1 - 3
  • [10] Polygenic Score for Physical Activity Is Associated with Multiple Common Diseases
    Sillanpaa, Elina
    Palviainen, Teemu
    Ripatti, Samuli
    Kujala, Urho M.
    Kaprio, Jaakko
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (02) : 280 - 287